CJC-1295 with DAC

Sold by case = 10 vials

CJC-1295 with DAC

For Research Use Only. Not for Human or Veterinary Consumption.

CJC-1295 with DAC is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) modified with a Drug Affinity Complex to extend its half-life. It is widely used in laboratory research to study sustained stimulation of endogenous growth hormone secretion and pituitary function. Researchers utilize this peptide to investigate endocrine signaling pathways, growth hormone axis regulation, and anabolic cellular processes in experimental models.

This product is provided solely for qualified laboratory research. Not approved for therapeutic, diagnostic, or human use.

Mechanism of Action

• Binds to growth hormone-releasing hormone (GHRH) receptors on pituitary somatotrophs, stimulating endogenous growth hormone release in experimental models.

• Modified with a Drug Affinity Complex (DAC) to extend peptide half-life, enabling prolonged receptor activation in laboratory studies.

• Investigated for effects on anabolic signaling pathways, tissue growth, and cellular regeneration under controlled conditions.

• Supports research into hypothalamic-pituitary axis modulation and endocrine feedback mechanisms.